Post de Capgemini Life Sciences and Healthcare

As we approach the close of another remarkable year, we're excited to reflect on our journey and share some of the recent successes we've achieved. We are thrilled to share that we've recently forged significant data licensing agreements with industry leaders such as Accenture, eTherapeutics, and other esteemed partners large and small in the biotech, pharma and technology sectors. These collaborations have not only strengthened our resolve but also underscored the profound value of GeneCards' integrated knowledgebase. Our integrated biomedical data, at the core of our partnerships, serves as a strong foundation for solutions in clinical diagnostics, drug discovery, and the development of cutting-edge AI solutions for healthcare, among other critical applications. As we look ahead, we invite you to connect with us and discover how our integrated data solutions can elevate your endeavors. Here's to a successful year-end and an even brighter future ahead! #GeneCards #HealthcareInnovation #aidrugdiscovery #aihealthcare #bioinformatics #biomedicalresearch

Count Down 4 days until PMWC 2024!  Join the discussion on Accelerating Drug Development Approvals Using RWE/D PMWC Track 2 AI& Data Sciences Silicon Valley January 25th (day 2), 2:00 - 3:00 pm  Panelists:  - Mika Newton, xCures (Chair) - Leo Russo, PhD, Pfizer - Eric Schadt, Pathos - Ashley Brenton, Ph.D., Optum - Nasha Fitter, Ciitizen 💡 Exploring Key Focus Areas: -Revolutionizing Clinical Trials: Harnessing Real-World Evidence/Data for Enhanced Drug Development. -Regulatory Navigation: Understanding and adapting to the evolving regulatory landscape. -Data Integrity and Quality: Prioritizing the reliability and accuracy of data in clinical studies. -Patient-Centric Approaches: Advancing drug development with a focus on patient needs. -Innovative Data Analysis: Utilizing cutting-edge techniques for insightful data interpretation. -Pharmaceutical Collaborations: Fostering partnerships for improved outcomes. -RWE/D Successes and Future Vision: Learning from success stories and predicting future trends. 🔬 This session is an essential platform for professionals in the pharmaceuticals, healthcare, and technology sectors. Don't miss this opportunity to delve into the future of drug development and gather valuable insights from leading industry experts! https://lnkd.in/gi_mHZdC Looking forward to seeing you all in a few days! PMWC - Precision Medicine World Conference #PMWC24 #precisionmedicine #drugdevelopment #realworldevidence #rwe #dataintegrity #PatientCentricApproaches #PharmaceuticalCollaborations #healthcaretechnology #ai #datasciences #clinicaltrials #dataquality #AcceleratingDrugDevelopment #RWEsuccess #DrugDevelopmentApprovals #realworlddata #pharma #biotech #lifesciences #healthcareindustry #medicalresearch #datasharing

FAIR isn't just about accessibility—it's about empowerment. Making data and analytics Findable, Accessible, Interoperable, and Reusable (FAIR) is important beyond academia, it’s also crucial in the biopharmaceutical industry. FAIR provides a foundation to advance knowledge within organizations and democratize access to insights. Dr. Jack DiGiovanna, CSO at Velsera, shared his insights on how embracing FAIR principles for data and analytics can help cross the chasm between basic research and novel therapeutics becoming standard of care during Bio-IT World 2024 earlier this month. FAIRness isn't without its challenges, especially when the principles are applied also to analytics. Time remains a powerful challenger, especially as the drug development life cycle with the standard turnover or reorganizations within the industry. Jack highlighted the importance of global standards, how they have been successfully applied, and where analytical platforms can serve as the bedrock of this transformative movement. Jack discussed how current platforms, especially in the NIH space, are paving the way for FAIR data and analysis; discussed key areas for future development; and highlighted where continuing support will be most impactful. Build a future where data isn't just collected—it's connected, shared, and utilized for meaningful impact with Velsera today! Make your analytics sharable, interpretable, and able to be validated. Contact us to learn more: https://lnkd.in/df3EP_2g #FAIRData #ResearchImpact #DataScience #Innovation

Pharmaceutical Executive highlights new skills such as #datascience, #AI, and #digital tools coming into the the pharmaceutical industry. The challenge lies in harnessing these skills quickly and effectively. This article explores how we can leverage these evolving talents to drive #innovation, create better medicines, and ultimately improve patient outcomes. Dive in for an exciting perspective on the future of #pharma! #PharmaLeadership #PharmaExec #Innovation #PatientCare https://lnkd.in/eAzJhBye

🔬 From Bench to Bedside: Bridging the Gap in Biopharma Innovation 🏥 Embark on a journey that spans the laboratory to the patient's bedside, connecting science with real-world impact. Here are 5 key points illuminating the bridge that closes the gap in biopharma innovation: 1. Seamless Translation of Discoveries: Witness the translation of groundbreaking discoveries from the laboratory bench to the bedside. Explore how biopharma is bridging the gap, ensuring that promising science translates into tangible benefits for patients. 2. Patient-Centric Design: Delve into the evolution of patient-centric drug development, where the needs and experiences of patients guide the innovation process. Discover how biopharma is not just developing treatments but designing solutions that resonate with those who need them. 3. Interdisciplinary Collaboration: Explore the collaborative spirit that unites researchers, clinicians, and industry experts. From diverse perspectives emerges a holistic approach to innovation, addressing challenges at every stage of the biopharma journey. 4. Accelerated Access to Therapies: Navigate the acceleration of therapies from discovery to market, shortening the timeline for patients to access life-changing treatments. Witness how bridging the innovation gap leads to faster, more efficient healthcare solutions. 5. Real-World Impact: Celebrate the real-world impact of biopharma innovations on patient outcomes. From improved treatment efficacy to enhanced quality of life, experience the transformative journey that brings innovation from the bench to the bedside. Join us in exploring the dynamic intersection of science and compassion as we bridge the gap in biopharma innovation. #impact #biopharma #innovation #healthcare

Learn more about our featured companies and their growth story B2i Digital #microcaps #growthstory

🔍 Discover the most compelling Pharma & Life Sciences narratives of 2023! 🌐 Dataiku's latest blog delves into the standout stories of 2023, spotlighting game-changing innovations that are reshaping clinical trials. Explore how the integration of analytics and AI has emerged as a pivotal game-changer, revolutionizing trial methodologies, accelerating drug development, and ultimately elevating patient outcomes. Stay ahead in clinical research - discover how data-driven insights are driving the future of healthcare. Read more here: https://lnkd.in/eUWU2ZHZ #PharmaInnovation #LifeSciences #AIinHealthcare #DataAnalytics #ClinicalTrials

How do we break through the barriers to expand real-world data use across pharma? ➡ Life science companies are engaged in a never-ending quest to get more effective, safer therapies to patients in a faster and more accessible manner.  ➡ But there are still unexplored areas of opportunity for strengthening – and shortening – the R&D pipeline.  And real-world data is at the top of that list. ➡ While the use of real-world data in clinical trials has increased since the pandemic, we’re still extracting only a fraction of the benefit that rich, curated, multi-modal, real-world information can provide to us. ➡ So the question remains, why aren’t more pharma companies using real-world data as a core component of research and development, especially when evidence is piling up that it can change the way we view drug development and precision medicine? 🔽 Read more on our blog 🔽 link in comments 🔽 #rwd #realworlddata #pharma #oncologyresearch #clinicaltrials

How can we harness novel technologies to spend less time in the lab and more time innovating? 💡 Join us on Thursday to discuss 💡 During the open discussion sessions at the Lab of the Future Congress USA 2024, it became apparent that our adoption of novel R&D technology lags behind other industries. Is the biopharma industry investing adequately in deploying digital technologies to improve R&D? How can we improve the slow adoption rates? Our latest free digital dialogue: ‘Digital Transformation – Where are we going wrong?’ creates a space for thought-provoking, open discussion between presenters and audience. The discussion will focus on the challenges associated with implementing new #digital and #automated technologies within biopharma, and what we can do to overcome these. This is the perfect opportunity to discuss common challenges with industry peers, to spark ideas and discussions that will continue after the session. The session is free to attend, but places are limited and you need to register to secure your place. ⏰ 16:30 CEST · 15:30 BST · 10:30 ET · 09:30 CT 📅 Thursday, May 9th Please come ready with questions and comments! Link: https://lnkd.in/e6SWy_xC Daniel Thomas Saleha Patel Markus Gershater AstraZeneca Synthace #digitaltransformation #labofthefuture #digitaljourney

Could not made the Webinar "The Biotech reset, Navigating the path forward"? Its now available on replay and If I can say so myself, this is a very interesting topic on key discussions for Biotech owners. If you want to connect to discuss send me a message. #IQVIAbiotech #biotech #thereset #movingforward